Thus, the inhibition of IL-1β by melatonin reported here suggests that the neuroinflammatory process in CMT1A neuropathy involves both NF-κB and NLRP3 inflammasome [20]. The gene discussed is NLRP3; the disease is Charcot-Marie-Tooth disease type 1A.